Key result
Immunoinformatics identifies five conserved B cell and several T cell epitopes on PEDV S glycoprotein.
Why the study?
Coronaviruses accumulate mutations that compromise immune responses elicited by outdated vaccines, necessitating the identification of conserved epitopes in the S glycoprotein of Mexican PEDV strains for vaccine development.
The identified conserved B and T cell epitopes in the PEDV S glycoprotein show potential for developing updated vaccines against Mexican PEDV strains.
Supports updated PEDV vaccine development for Mexican strains; hypothesis-generating and should not yet change practice.
The porcine epidemic diarrhea virus (PEDV) causes a gastrointestinal disease generating mortality rates approaching 100% in piglets worldwide. The S glycoprotein of PEDV is the main target for the development of vaccines. Two vaccines approved by the Ministry of Agriculture and Rural Development are used in Mexico: the first vaccine is based on an inactivated virus isolated more than a decade ago, whereas the second vaccine is based on mRNA technology. The most important tool for controlling PEDV outbreaks is vaccination; however, coronaviruses are characterized by the accumulation of multiple mutations, which compromise the immune response elicited by outdated vaccines. In this work, we classified the Mexican strains of PEDV reported so far in GenBank, according to their genotypes. Subsequently, we searched for B and T cell epitopes conserved in Mexican PEDV strains using bioinformatic tools. In addition, we explored whether these epitopes can induce allergies, autoimmunity, and/or toxic effects. Next, we determined the localization of B cell epitopes in the S glycoprotein using the protein crystal and protein modeling of several S glycoproteins. Finally, we carried out molecular docking analysis to assess whether these T cell epitopes could interact with the peptide-binding groove of the Swine Leukocyte Antigens (SLAs). Five conserved B cell epitopes were found to be exposed on the surface of the S glycoprotein, whereas several promiscuous CTL and HTL epitopes were bound, with low free energy, to the peptide-binding grooves of SLA-I and SLA-II, respectively. The best epitopes were used to generate a plasmid carrying the sequence to produce a recombinant protein. This plasmid was used for transfection experiments in PK-15 cell culture. The B cell epitopes reported here were recognized by the sera from pigs infected with PEDV but not by the sera from uninfected animals. These results justify future evaluations of the ability of these epitopes to stimulate cytokine production by T cells, antibody generation, and their neutralizing activity.
No takes yet. Share an insight, caveat, or question.
Zepeda-Cervantes et al. (2026) studied this question. Five conserved B cell epitopes identified on the PEDV S glycoprotein were specifically recognized by sera from infected pigs, alongside several T cell epitopes that strongly bound to SLAs.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: